Evommune, Inc. (NYSE: EVMN) last traded at $14.02, up 3.32% on the session. The quote above updates while this page is open; the figures below are drawn from Evommune, Inc.’s own filings and are restated only when a new one is published.
Evommune, Inc. trades on NYSE under the ticker EVMN. Its market capitalisation is $508.82 million.
Valuation measures for Evommune, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $508.82M |
|---|---|
| Enterprise value | $473.14M |
| Price / sales | 50.88 |
| Price / book | 1.83 |
| Beta | 1.00 |
Trailing-twelve-month figures tagged in Evommune, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $10.00M |
|---|---|
| Net income (TTM) | -$94.67M |
| Operating margin | -1018.94% |
| Return on equity | -34.10% |
| Cash | $60.03M |
Range and volume for EVMN over the past 52 weeks.
| 52-week high | $33.20 |
|---|---|
| 52-week low | $10.47 |
| Volume | 275.1K |
| Average volume | 794.5K |
| Previous close | $13.57 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.